The Long Non-Coding RNA AC006329.1 Facilitates Hepatocellular Carcinoma Progression and Metastasis by Regulating miR-127-5p/SHC3/ERK Axis

References

• Huang Z, Zhou J-K, Peng Y, et al. The role of long noncoding RNAs in hepatocellular carcinoma. Mol Cancer. 2020;19(1):77. doi:10.1186/s12943-020-01188-4
   PubMed Web of Science ®Google Scholar
• Lin J, Wu L, Bai X, et al. Combination treatment including targeted therapy for advanced hepatocellular carcinoma. Oncotarget. 2016;7(43):71036–71051. doi:10.18632/oncotarget.11954
   PubMedGoogle Scholar
• Zhang X, Wszolek ZK, Wolters EC, et al. Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int J Mol Sci. 2019;20(22):5573. doi:10.3390/ijms20225573
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang L, Chen T, et al. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Mol Cancer. 2019;18(1):28. doi:10.1186/s12943-019-0957-7
   PubMed Web of Science ®Google Scholar
• Pradhan AK, Emdad L, Das SK, et al. The Enigma of miRNA regulation in cancer. Adv Cancer Res. 2017;135:25–52.
   PubMed Web of Science ®Google Scholar
• Song J, Wang Q, Luo Y, et al. miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS. Int J Clin Exp Pathol. 2015;8(10):12728–12737.
   PubMed Web of Science ®Google Scholar
• Khan A, Zhang X. Function of the Long Noncoding RNAs in hepatocellular carcinoma: classification, molecular mechanisms, and significant therapeutic potentials. Bioengineering. 2022;9:8.
   Google Scholar
• Teng F, Zhang J-X, Chang Q-M, et al. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39(1):235. doi:10.1186/s13046-020-01739-z
   PubMed Web of Science ®Google Scholar
• Smolarz B, Zadrożna-Nowak A, Romanowicz H. The Role of lncRNA in the development of tumors, including breast cancer. Int J Mol Sci. 2021;22(16):8427. doi:10.3390/ijms22168427
   PubMed Web of Science ®Google Scholar
• He H, Wang Y, Ye P, et al. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39(1):159. doi:10.1186/s13046-020-01664-1
   PubMed Web of Science ®Google Scholar
• Liu Y, Wei G, Ma Q, et al. Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis. Thorac Cancer. 2020;11(2):394–407. doi:10.1111/1759-7714.13283
   PubMed Web of Science ®Google Scholar
• Ma H-W, Xi D-Y, Ma J-Z, et al. Long Noncoding RNA AFAP1-AS1 promotes cell proliferation and metastasis via the miR-155-5p/FGF7 axis and predicts poor prognosis in gastric cancer. Dis Markers. 2020;2020:8140989. doi:10.1155/2020/8140989
   PubMed Web of Science ®Google Scholar
• Liu SJ, Dang HX, Lim DA, et al. Long noncoding RNAs in cancer metastasis. Nat Rev Cancer. 2021;21(7):446–460. doi:10.1038/s41568-021-00353-1
   PubMed Web of Science ®Google Scholar
• Yao X, Wu L, Gu Z, et al. LINC01535 promotes the development of osteosarcoma through modulating miR-214-3p/KCNC4 Axis. Cancer Manag Res. 2020;12:5575–5585. doi:10.2147/CMAR.S232757
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu J, Cui J, et al. Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis. Bioengineered. 2022;13(1):1115–1125. doi:10.1080/21655979.2021.2017678
   PubMed Web of Science ®Google Scholar
• Guo D, Li Y, Chen Y, et al. DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1 pathway. Cell Prolif. 2019;52(4):e12628. doi:10.1111/cpr.12628
   PubMed Web of Science ®Google Scholar
• Liang M, Yao W, Shi B, et al. Circular RNA hsa_circ_0110389 promotes gastric cancer progression through upregulating SORT1 via sponging miR-127-5p and miR-136-5p. Cell Death Dis. 2021;12(7):639. doi:10.1038/s41419-021-03903-5
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhu L, Yang G, et al. Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p. Biosci Rep. 2020;40(7):BSR20191418.
   PubMedGoogle Scholar
• Brabletz S, Schuhwerk H, Brabletz T, et al. Dynamic EMT: a multi-tool for tumor progression. EMBO j. 2021;40(18):e108647. doi:10.15252/embj.2021108647
   PubMed Web of Science ®Google Scholar
• Wang X, Lai Q, He J, et al. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1. Int J Med Sci. 2019;16(1):51–59. doi:10.7150/ijms.27359
   PubMed Web of Science ®Google Scholar
• Li WJ, Li G, Liu Z-W, et al. LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/HMGA2 axis. Neoplasma. 2021;68(6):1225–1235. doi:10.4149/neo_2021_210427N574
   PubMed Web of Science ®Google Scholar
• Zhou M, Bian Z, Liu B, et al. Long noncoding RNA MCM3AP-AS1 enhances cell proliferation and metastasis in colorectal cancer by regulating miR-193a-5p/SENP1. Cancer Med. 2021;10(7):2470–2481. doi:10.1002/cam4.3830
   PubMed Web of Science ®Google Scholar
• Fen H, Hongmin Z, Wei W, et al. RHPN1-AS1 drives the progression of hepatocellular carcinoma via regulating miR-596/IGF2BP2 Axis. Curr Pharm Des. 2020;25(43):4630–4640.
   PubMed Web of Science ®Google Scholar
• Guo Q, Zhang Q, Lu L, et al. Long noncoding RNA RUSC1-AS1 promotes tumorigenesis in cervical cancer by acting as a competing endogenous RNA of microRNA-744 and consequently increasing Bcl-2 expression. Cell Cycle. 2020;19(10):1222–1235. doi:10.1080/15384101.2020.1749468
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang X, Yang B, et al. Demethylation-Induced Overexpression of Shc3 Drives c-Raf-Independent Activation of MEK/ERK in HCC. Cancer Res. 2018;78(9):2219–2232. doi:10.1158/0008-5472.CAN-17-2432
   PubMed Web of Science ®Google Scholar
• Miyake I, Hakomori Y, Misu Y, et al. Domain-specific function of ShcC docking protein in neuroblastoma cells. Oncogene. 2005;24(19):3206–3215. doi:10.1038/sj.onc.1208523
   PubMed Web of Science ®Google Scholar
• De Falco V, Guarino V, Malorni L, et al. RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumors. Oncogene. 2005;24(41):6303–6313. doi:10.1038/sj.onc.1208776
   PubMed Web of Science ®Google Scholar
• Magrassi L, Conti L, Lanterna A, et al. Shc3 affects human high-grade astrocytomas survival. Oncogene. 2005;24(33):5198–5206. doi:10.1038/sj.onc.1208708
   PubMed Web of Science ®Google Scholar
• Wang L, Wang L, Zhang H, et al. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway. Oncol Rep. 2020;43(5):1558–1568. doi:10.3892/or.2020.7523
   PubMed Web of Science ®Google Scholar
• Xu JC, Chen T-Y, Liao L-T, et al. NETO2 promotes esophageal cancer progression by inducing proliferation and metastasis via PI3K/AKT and ERK pathway. Int J Biol Sci. 2021;17(1):259–270. doi:10.7150/ijbs.53795
   PubMed Web of Science ®Google Scholar